23h
Medpage Today on MSNSemaglutide Tied to Small Risk of Potentially Blinding Eye ConditionThe use of semaglutide (Ozempic) was tied to a small risk of nonarteritic anterior ischemic optic neuropathy (NAION) in ...
Adding the anti-CD20 monoclonal antibody obinutuzumab (Gazyva) to standard therapy for lupus nephritis is more efficacious ...
Genentech and Novartis have teamed up with Food Allergy Research & Education (FARE) to enhance the safety of children with ...
To learn more about food allergies or access FARE resources, please visit foodallergy.org.
BioMed X Institute is teaming up with the Barbados government in an effort to accelerate cardiometabolic treatments for ...
Immune cell populations of people with post-vaccination syndrome had lower levels of effector CD4 T cells and higher levels ...
Roche's innovative sequencing by expansion (SBX) technology represents a leap forward in next-generation sequencing (NGS), ...
Roche's innovative sequencing by expansion (SBX) technology represents a leap forward in next-generation sequencing (NGS), which is playing a vital role in decoding complex diseases like cancer, immun ...
2d
Stockhead on MSNBiocurious: Cashed up and pursuing the ‘c’ word, Imugene is on the verge of transforming cancer immunotherapyImugene's trial programs could result in the first 'off the shelf' Car-T therapy that uses healthy donors' cells.
23h
Hosted on MSNState's community colleges mark Career Education MonthIt's an economic engine not only for California but also for the United States, and remains the nation's largest workforce training provider: the Golden State's community colleges. And this month the ...
The FDA has approved Evrysdi in tablet form for patients with spinal muscular atrophy aged 2 years and older who weigh more ...
As a biologics CDMO focused on developing and manufacturing recombinant protein products using mammalian cell culture ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results